School of Molecular and Cellular Biology, University of Leeds, Leeds, United Kingdom.
INGENASA, Inmunología y Genética Aplicada S.A., Madrid, Spain.
PLoS Negl Trop Dis. 2020 Jun 3;14(6):e0008364. doi: 10.1371/journal.pntd.0008364. eCollection 2020 Jun.
Crimean-Congo hemorrhagic fever orthonairovirus (CCHFV) is one of the most widespread medically important arboviruses, causing human infections that result in mortality rates of up to 60%. We describe the selection of a high-affinity small protein (Affimer-NP) that binds specifically to the nucleoprotein (NP) of CCHFV. We demonstrate the interference of Affimer-NP in the RNA-binding function of CCHFV NP using fluorescence anisotropy, and its inhibitory effects on CCHFV gene expression in mammalian cells using a mini-genome system. Solution of the crystallographic structure of the complex formed by these two molecules at 2.84 Å resolution revealed the structural basis for this interference, with the Affimer-NP binding site positioned at the critical NP oligomerization interface. Finally, we validate the in vitro application of Affimer-NP for the development of enzyme-linked immunosorbent and lateral flow assays, presenting the first published point-of-care format test able to detect recombinant CCHFV NP in spiked human and animal sera.
克里米亚-刚果出血热病毒(CCHFV)是最重要的医学重要虫媒病毒之一,导致人类感染,死亡率高达 60%。我们描述了一种高亲和力的小蛋白(Affimer-NP)的选择,该蛋白特异性结合 CCHFV 的核蛋白(NP)。我们使用荧光各向异性证明了 Affimer-NP 对 CCHFV NP 的 RNA 结合功能的干扰,并用微基因组系统证明了其对哺乳动物细胞中 CCHFV 基因表达的抑制作用。这两种分子形成的复合物的晶体结构的解决方案以 2.84 Å 的分辨率揭示了这种干扰的结构基础,Affimer-NP 的结合位点位于关键的 NP 寡聚化界面上。最后,我们验证了 Affimer-NP 在酶联免疫吸附和侧向流动测定中的体外应用,提出了第一个可检测已发表的用于检测重组 CCHFV NP 的点护理格式测试,可在人类和动物血清中检测到重组 CCHFV NP。